Trademark: 79246706
Word

Status
Registered
Status Code
700
Status Date
Tuesday, February 11, 2020
Serial Number
79246706
Registration Number
5980146
Registration Date
Tuesday, February 11, 2020
Mark Type
2000
Filing Date
Monday, July 2, 2018
Published for Opposition
Tuesday, November 26, 2019

Trademark Owner History

Classifications
5 Royal jelly for pharmaceutical purposes; medicinal drinks; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Chemico pharmaceutical preparations for the treatment of hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, Alzheimer's disease, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, tumor, vision loss and blindness in the elderly; Depuratives for the body; Medicines for human purposes, namely, Hypoglycemic drugs, Organotherapeutic drugs, Antitumor drugs, Antiepileptic drugs, Anti-cancer drugs, Antiviral drugs for treating influenza, Cytostatic drugs for medical purposes, Antipyretic drugs with sedative effect, Cardiovascular drugs used in myocardial infarction, Cardiovascular drugs used in treating arrhythmias, Cardiovascular drugs used in angina pectoris, Cardiovascular drugs for use in treating hypertension, Medicines for treating intestinal disorders, Non-prescription medicines, namely, pills, tablets, capsules, caplets for the treatment of hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, tumor, cancer, vision loss and blindness in the elderly, Medicines for the treatment of gastrointestinal diseases, Medicines for alleviating constipation;pesticides; Biomedicines for the treatment of hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, tumor, cancer, vision loss and blindness in the elderly; Medicines for veterinary purposes, namely, Anti-infective products for veterinary use, Bacterial preparations for medical and veterinary use, Veterinary vaccines; Transdermal patches for use in the treatment of circulating the blood, relaxing the muscles and joints, reducing swelling and pain, treating bruises, eliminating fatigue before and after sports; Nutritive substances for microorganism for medical purposes; disinfectants; tissues impregnated with antibacterial preparations; dental lacquer; medicinal tea; Chemical preparations for pharmaceutical purposes for the treatment of hepatitis, dizziness, cardiovascular diseases, cerebrovascular diseases, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach diseases, digestive diseases, restlessness, laryngitis, pharyngitis, tonsillitis, tracheitis, pneumonia, influenza, cough, diabetes, nephropathy, eye diseases, vision loss and blindness in the elderly; Capsules for medicines, namely, Allergy capsules, Decongestant capsules, Herbal male enhancement capsules, Ginseng capsules for medical purposes; Pharmaceutical preparations for the treatment of central nervous system diseases, fundus diseases, vascular diseases, diabetes, schizophrenia, depression, anxiety disorders, insomnia, hypertension, hyperlipidemia, dyspepsia, gastritis, abdominal pain, gallbladder diseases, laryngitis, pharyngitis, gingivitis, constipation, respiratory diseases, influenza, cough, bronchitis, asthma, Alzheimer's disease, cancer, tumor; medicinal alcohol; gases for medical purposes; Dietetic substances in the nature of beverages adapted for medical use; bath preparations, medicated; diagnostic agents for medical purposes; Raw material medicine for the treatment of hepatitis, dizziness, cardiovascular disease, cerebrovascular disease, depression, schizophrenia, insomnia, cholecystitis, gallstones, stomach problems, digestive diseases, irritability, laryngitis, pharyngitis, tonsillitis, bronchitis, pneumonia, Influenza, cough, diabetes, nephropathy, eye disease, cancer, vision loss and blindness in the elderly; pearl powder for medical purposes; Prepared Chinese medicine for the treatment of dizziness, palpitation, insomnia, irritability, nausea, paralysis, back pain, shoulder pain, hypertension, hyperlipidemia, acute stroke, hemiplegia, cerebral infarction, stroke, Alzheimer's disease, heart disease, influenza, diabetes, depression, cancer, tumor, fundus diseases; Bag filled with Chinese medicine for the treatment of dizziness, palpitations, insomnia, irritability, nausea, paralysis, back pain, shoulder pain, hypertension, hyperlipidemia, acute stroke, hemiplegia, cerebral infarction, stroke, Alzheimer's disease, heart disease, influenza, diabetes, depression, cancer, tumor, fundus disease
Color is not claimed as a feature of the mark.
The mark consists of three stylized Asian characters.
The transliteration of the non-Latin characters in the mark is: The Chinese characters in the mark are transliterated into "KE LUO XIN".
The English translation of "KE LUO XIN" is "THIRSTY" "COLLATERALS" "JOYFUL"

Trademark Events
Jun 5, 2021
New Representative At Ib Received
Aug 14, 2020
Final Decision Transaction Processed By Ib
May 27, 2020
Generic Madrid Transaction Sent To Ib
May 27, 2020
Generic Madrid Transaction Created
May 11, 2020
Final Disposition Notice Created, To Be Sent To Ib
Feb 11, 2020
Registered-Principal Register
Nov 26, 2019
Official Gazette Publication Confirmation E-Mailed
Nov 26, 2019
Published For Opposition
Nov 6, 2019
Notification Of Notice Of Publication E-Mailed
Oct 21, 2019
Assigned To Lie
Oct 16, 2019
Approved For Pub - Principal Register
Oct 14, 2019
Teas/Email Correspondence Entered
Oct 14, 2019
Correspondence Received In Law Office
Oct 14, 2019
Teas Request For Reconsideration Received
May 20, 2019
Notification Of Final Refusal Emailed
May 20, 2019
Final Refusal E-Mailed
May 20, 2019
Final Refusal Written
May 7, 2019
Teas/Email Correspondence Entered
May 7, 2019
Correspondence Received In Law Office
May 7, 2019
Teas Response To Office Action Received
Jan 5, 2019
Refusal Processed By Ib
Dec 16, 2018
Non-Final Action Mailed - Refusal Sent To Ib
Dec 16, 2018
Refusal Processed By Mpu
Dec 7, 2018
Application Filing Receipt Mailed
Dec 5, 2018
Non-Final Action (Ib Refusal) Prepared For Review
Dec 4, 2018
Non-Final Action Written
Dec 3, 2018
Assigned To Examiner
Dec 3, 2018
New Application Office Supplied Data Entered In Tram
Nov 29, 2018
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24